日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

N-Dihydrogalactochitosan Drives Conventional and Alternative Activations of STING to Synergize Type I IFN and IL-1β Productions for Antitumor Immunity

N-二氢半乳壳聚糖驱动STING的常规和替代激活，从而协同作用产生I型干扰素和IL-1β，增强抗肿瘤免疫力

期刊:Advanced Functional Materials
影响因子:18.5
doi:10.1002/adfm.202410079
Ashley R Hoover ，Kaili Liu ，Coline Furrer ，Samuel Siu Kit Lam ，David W Anderson ，Zhijun Zhou ，Jingxuan Yang ，Chun Fung Wong ，Alexandra D Medcalf ，Xiao-Hong Sun ，Tomas Hode ，Lu Alleruzzo ，Abby Delawder ，Joseph Raker ，Ghainaa Abousleiman ，Trisha I Valerio ，Yuanhong Sun ，James F Papin ，Min Li ，Wei R Chen
STING
IL-1β
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2024
文献求助 收藏

Preliminary 3-Year Evaluation of Experience With SilkSurface and VelvetSurface Motiva Silicone Breast Implants: A Single-Center Experience With 5813 Consecutive Breast Augmentation Cases

对使用SilkSurface和VelvetSurface Motiva硅胶乳房假体的初步3年评估：单中心5813例连续隆胸病例的经验

期刊:Aesthetic Surgery Journal
影响因子:3.9
doi:10.1093/asj/sjx150
Sforza, Marcos; Zaccheddu, Renato; Alleruzzo, Angelo; Seno, Adriano; Mileto, Domenico; Paganelli, Arnaldo; Sulaiman, Hassan; Payne, Michael; Maurovich-Horvat, Lajos
发表日期：2018
文献求助 收藏

Development of inCVAX, In situ Cancer Vaccine, and Its Immune Response in Mice with Hepatocellular Cancer

原位癌症疫苗 inCVAX 的开发及其在肝细胞癌小鼠中的免疫反应

期刊:
影响因子:
doi:10.4172/2155-9899.1000438
Xiaoqiang Qi, Samuel Sk Lam, Dai Liu, Dae Young Kim, Lixin Ma, Lu Alleruzzo, Wei Chen, Tomas Hode, Carolyn J Henry, Jussuf Kaifi, Eric T Kimchi, Guangfu Li, Kevin F Staveley-O'Carroll
肿瘤
肝癌
其它细胞
发表日期：2016
文献求助 收藏

InCVAX--a novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity

InCVAX——一种通过光免疫疗法诱导肿瘤特异性免疫来治疗晚期转移性癌症的新策略

期刊:Cancer Letters
影响因子:10.1
doi:10.1016/j.canlet.2015.01.029
Zhou, Feifan; Li, Xiaosong; Naylor, Mark F; Hode, Tomas; Nordquist, Robert E; Alleruzzo, Luciano; Raker, Joseph; Lam, Samuel S K; Du, Nan; Shi, Lei; Wang, Xiuli; Chen, Wei R
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2015
文献求助 收藏